Deficiency of orexin receptor type 1 in dopaminergic neurons increases novelty-induced locomotion and exploration
eLife · 2025
DOI: 10.7554/elife.91716 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Xing Xiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute for Metabolism Research, Department of Neuronal Control of Metabolism, Cologne, Germany. Hauptthemen laut MEDLINE: Dopaminergic Neurons, Orexin Receptors, Locomotion, Exploratory Behavior. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Helmholtz Association.
Abstract (Originalsprache)
Orexin signaling in the ventral tegmental area and substantia nigra promotes locomotion and reward processing, but it is not clear whether dopaminergic neurons directly mediate these effects. We show that dopaminergic neurons in these areas mainly express orexin receptor subtype 1 (Ox1R). In contrast, only a minor population in the medial ventral tegmental area express orexin receptor subtype 2 (Ox2R). To analyze the functional role of Ox1R signaling in dopaminergic neurons, we deleted Ox1R specifically in dopamine transporter-expressing neurons of mice and investigated the functional consequences. Deletion of Ox1R increased locomotor activity and exploration during exposure to novel environments or when intracerebroventricularely injected with orexin A. Spontaneous activity in home cages, anxiety, reward processing, and energy metabolism did not change. Positron emission tomography imaging revealed that Ox1R signaling in dopaminergic neurons affected distinct neural circuits depending on the stimulation mode. In line with an increase of neural activity in the lateral paragigantocellular nucleus (LPGi) of Ox1R ΔDAT mice, we found that dopaminergic projections innervate the LPGi in regions where the inhibitory dopamine receptor subtype D2 but not the excitatory D1 subtype resides. These data suggest a crucial regulatory role of Ox1R signaling in dopaminergic neurons in novelty-induced locomotion and exploration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Max Planck Institute for Metabolism Research, Department of Neuronal Control of Metabolism, Cologne, Germany.
- Department of Biology, Institute for Zoology, University of Cologne, Cologne, Germany.
- Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
- Max Planck Institute for Metabolism Research, Multimodal Imaging of Brain Metabolism Group, Cologne, Germany.
ORCID-Profile: Xing Xiao, Peter Kloppenburg
Förderung
- Deutsche Forschungsgemeinschaft
- Helmholtz Association
Zitieren
APA
Xiao, X., Yeghiazaryan, G., Eggersmann, F., Cremer, A. L., Backes, H., Kloppenburg, P., & Hausen, A. C. (2025). Deficiency of orexin receptor type 1 in dopaminergic neurons increases novelty-induced locomotion and exploration. eLife. https://doi.org/10.7554/elife.91716
Vancouver
Xiao X, Yeghiazaryan G, Eggersmann F, Cremer AL, Backes H, Kloppenburg P, et al. Deficiency of orexin receptor type 1 in dopaminergic neurons increases novelty-induced locomotion and exploration. eLife. 2025. doi:10.7554/elife.91716
BibTeX
@article{Xiao2025,
author = {Xiao, Xing and Yeghiazaryan, Gagik and Eggersmann, Fynn and Cremer, Anna Lena and Backes, Heiko and Kloppenburg, Peter and Hausen, Anne Christine},
title = {Deficiency of orexin receptor type 1 in dopaminergic neurons increases novelty-induced locomotion and exploration},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.91716}
}
EUVIMED